Neurocrine Biosciences
NBIX
#1633
Rank
NZ$16.89 B
Marketcap
$170.81
Share price
1.28%
Change (1 day)
-24.19%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): NZ$0.85 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are NZ$2.35 Billion. , an increase over its 2023 earnings that were of NZ$0.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.86 B64.57%
2023 NZ$0.52 B41.13%
2022 NZ$0.37 B73.74%
2021 NZ$0.21 B-8.82%
2020 NZ$0.23 B77.78%
2019 NZ$0.13 B49.83%
2018 NZ$88.23 M-142.57%
2017 -NZ$0.21 Billion-14.73%
2016 -NZ$0.25 Billion53.15%
2015 -NZ$0.16 Billion46.25%
2014 -NZ$0.11 Billion29.66%
2013 -NZ$83.7 Million-3530.8%
2012 NZ$2.43 M-95.73%
2011 NZ$57.15 M
2009 -NZ$80.35 Million-45.38%
2008 -NZ$0.15 Billion-58.87%
2007 -NZ$0.36 Billion87.3%
2006 -NZ$0.2 Billion351.97%
2005 -NZ$42.25 Million-52.09%
2004 -NZ$88.18 Million-10.98%
2003 -NZ$99.05 Million
2001 -NZ$73.94 Million
1999 -NZ$33.35 Million108.32%
1998 -NZ$16.01 Million
1996 NZ$4.88 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$10.63 Million-101.23%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.62 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-NZ$45.39 Million-105.25%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$21.36 B 2,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.26 B 623.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$18.72 B 2,065.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$37.43 Million-104.33%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$70.37 Million-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA